WINDTREE THERAPEUTICS INC /DE/ Repayments of Long-Term Debt
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2022-03-31
- WINDTREE THERAPEUTICS INC /DE/ repayments of long-term debt for the quarter ending 2021-12-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ repayments of long-term debt for the quarter ending 2021-09-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ repayments of long-term debt for the quarter ending 2020-12-31 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ repayments of long-term debt for the quarter ending 2020-09-30 was $0.00.
- WINDTREE THERAPEUTICS INC /DE/ repayments of long-term debt for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- WINDTREE THERAPEUTICS INC /DE/ repayments of long-term debt for fiscal 2020 was $547.00K.
- WINDTREE THERAPEUTICS INC /DE/ repayments of long-term debt for fiscal 2017 was $2.50M.
- WINDTREE THERAPEUTICS INC /DE/ repayments of long-term debt for fiscal 2015 was $5.00M.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $0.00 10-K · filed 2022-03-31 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-08-05 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $0.00 derived: sum of 2 quarters · filed 2022-03-31 | $547.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $547.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $547.00K 10-Q · filed 2021-08-05 | |||
| 2017-12-31 | $2.50M 10-K/A · filed 2019-04-23 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $5.00M 10-K · filed 2017-03-31 | ||
| 2015-09-30 | $5.00M 10-Q · filed 2016-11-14 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $0.00 10-K · filed 2016-03-29 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-05 | |||
| 2012-12-31 | $0.00 10-K · filed 2013-03-15 | |||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $0.00 derived: sum of 2 quarters · filed 2013-03-15 | $0.00 10-K · filed 2013-03-15 | |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | ||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $4.00M derived: sum of 2 quarters · filed 2013-03-15 | $8.50M 10-K · filed 2013-03-15 | |
| 2010-09-30 | $4.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $8.50M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $4.50M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |